CN102960456B - Xylooligosaccharide milk tablet - Google Patents
Xylooligosaccharide milk tablet Download PDFInfo
- Publication number
- CN102960456B CN102960456B CN201210537196.9A CN201210537196A CN102960456B CN 102960456 B CN102960456 B CN 102960456B CN 201210537196 A CN201210537196 A CN 201210537196A CN 102960456 B CN102960456 B CN 102960456B
- Authority
- CN
- China
- Prior art keywords
- xylo
- oligosaccharide
- xylooligosaccharide
- milk
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 title claims abstract description 45
- 235000013336 milk Nutrition 0.000 title claims abstract description 40
- 239000008267 milk Substances 0.000 title claims abstract description 40
- 210000004080 milk Anatomy 0.000 title claims abstract description 40
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 39
- 241001061264 Astragalus Species 0.000 claims abstract description 34
- 235000006533 astragalus Nutrition 0.000 claims abstract description 34
- 210000004233 talus Anatomy 0.000 claims abstract description 34
- 235000015165 citric acid Nutrition 0.000 claims abstract description 13
- 238000002360 preparation method Methods 0.000 claims abstract description 13
- 235000010447 xylitol Nutrition 0.000 claims abstract description 13
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 11
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000000811 xylitol Substances 0.000 claims abstract description 11
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 11
- 229960002675 xylitol Drugs 0.000 claims abstract description 11
- 239000002245 particle Substances 0.000 claims abstract description 8
- 239000000843 powder Substances 0.000 claims description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 23
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 13
- 235000020985 whole grains Nutrition 0.000 claims description 8
- -1 dry Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 claims description 3
- 238000005469 granulation Methods 0.000 claims description 3
- 230000003179 granulation Effects 0.000 claims description 3
- 239000008188 pellet Substances 0.000 claims description 3
- 238000006116 polymerization reaction Methods 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 235000000346 sugar Nutrition 0.000 claims description 3
- 229960003487 xylose Drugs 0.000 claims description 3
- 235000021374 legumes Nutrition 0.000 claims description 2
- 229920001542 oligosaccharide Polymers 0.000 claims description 2
- 230000036039 immunity Effects 0.000 abstract description 10
- 150000004676 glycans Chemical class 0.000 abstract description 5
- 229920001282 polysaccharide Polymers 0.000 abstract description 5
- 239000005017 polysaccharide Substances 0.000 abstract description 5
- 235000008476 powdered milk Nutrition 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 230000007413 intestinal health Effects 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 4
- 235000019359 magnesium stearate Nutrition 0.000 abstract 2
- 210000000748 cardiovascular system Anatomy 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 235000019441 ethanol Nutrition 0.000 description 10
- 230000000694 effects Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 238000007873 sieving Methods 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229960004793 sucrose Drugs 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- LGQKSQQRKHFMLI-SJYYZXOBSA-N (2s,3r,4s,5r)-2-[(3r,4r,5r,6r)-4,5,6-trihydroxyoxan-3-yl]oxyoxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)OC1 LGQKSQQRKHFMLI-SJYYZXOBSA-N 0.000 description 1
- JCSJTDYCNQHPRJ-UHFFFAOYSA-N 20-hydroxyecdysone 2,3-acetonide Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(OC2C(C(O)C(O)OC2)O)OC1 JCSJTDYCNQHPRJ-UHFFFAOYSA-N 0.000 description 1
- LGQKSQQRKHFMLI-UHFFFAOYSA-N 4-O-beta-D-xylopyranosyl-beta-D-xylopyranose Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(O)OC1 LGQKSQQRKHFMLI-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- SQNRKWHRVIAKLP-UHFFFAOYSA-N D-xylobiose Natural products O=CC(O)C(O)C(CO)OC1OCC(O)C(O)C1O SQNRKWHRVIAKLP-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- JVZHSOSUTPAVII-UHFFFAOYSA-N Xylotetraose Natural products OCC(OC1OCC(OC2OCC(OC3OCC(O)C(O)C3O)C(O)C2O)C(O)C1O)C(O)C(O)C=O JVZHSOSUTPAVII-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- JCSJTDYCNQHPRJ-FDVJSPBESA-N beta-D-Xylp-(1->4)-beta-D-Xylp-(1->4)-D-Xylp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)C(O)OC2)O)OC1 JCSJTDYCNQHPRJ-FDVJSPBESA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000020121 low-fat milk Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- ABKNGTPZXRUSOI-UHFFFAOYSA-N xylotriose Natural products OCC(OC1OCC(OC2OCC(O)C(O)C2O)C(O)C1O)C(O)C(O)C=O ABKNGTPZXRUSOI-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a xylooligosaccharide milk tablet. The xylooligosaccharide milk tablet comprises the following components by weight: 5 to 20 parts of astragalus polysaccharide, 5 to 20 parts of xylooligosaccharide, 40 to 80 parts of powdered milk, 6 to 12 parts of xylitol, 0.01 to 1 part of citric acid, and 0.15 to 0.5 part of magnesium stearate. A preparation method of the xylooligosaccharide milk tablet comprises the following steps of: (1) pre-mixing: uniformly mixing the xylooligosaccharide, astragalus polysaccharide, xylitol, citric acid and powdered milk; (2) pelleting; (3) arranging the particles; and (4) tabletting: adding magnesium stearate to the dried particles, uniformly mixing, and then transferring into a tabletting machine to tablet, thus obtaining the xylooligosaccharide milk tablet. According to the xylooligosaccharide milk tablet, the astragalus polysaccharide is compounded with the xylooligosaccharide, and various nutritional agents act together, so that the value of the nourishment can be greatly improved. The nourishment prepared by the preparation method can effectively improve the immunity of organisms, protect the cardiovascular system, adjust the intestinal health, and the like after long-term consumption.
Description
Technical field
The present invention relates to a kind of milk sheet that contains astragalus polyose, xylo-oligosaccharide, belong to field of health care food.
Background technology
The Radix Astragali contains the various bioactivators such as polysaccharide, protein, alkaloid amino acid, flavonoids, glucoside, trace element, and wherein the immunocompetence of astragalus polyose is particularly outstanding.The pharmacological action of astragalus polyose: 1, antivirus action: astragalus polyose has obvious spread effect to interferon system, makes body produce endogenous interferon, suppresses copying of virus, thereby reaches antiviral object.2, antibacterial actions: but astragalus polyose has directly and kills and detoxication bacterium and viral product thereof, and main is brings into play by transferring immunity of organism defense function that strengthening vital QI to eliminate pathogenic factors is antibacterial, the effect of sterilization.3, enhanced machine body immunity function: astragalus polyose can specificity and nonspecific eliminating invade the foreign matter of body, specific immune and nonspecific immunity are all had to facilitation, improve the resist ability of body.
Xylo-oligosaccharide claims again wood oligose, is the functional polymerization sugar being combined into β-Isosorbide-5-Nitrae glycosidic bond by 2-9 wood sugar molecule, wherein/and to take xylobiose, xylotriose, Xylotetrose be main active ingredient; Outward appearance is white or pale yellow powder, has good heat resistance and acid resistance; Sugariness is about 40% of sucrose, and its sweet taste is pure, with sucrose seemingly, can as sweetener, use by part substituting saccharose; Xylo-oligosaccharide is substantially identical with glucose on the impact of water activity, can be used as NMF and uses in food; Its viscosity is very low, with temperature, raises and declines rapidly, in the interpolation of various forms product, processes, and seems very convenient.The physiological function of xylo-oligosaccharide comprises: reduce the generation of harmful tunning and harmful bacteria; suppress pathogen; prevent diarrhoea, improve constipation, protection liver; reduce serum cholesterol; reduce blood pressure, strengthen immunity of organisms, anticancer; impel body to generate multiple nutrients material, there is good compatibility.
Have not yet to see astragalus polyose and the composite report of making dietetic product of xylo-oligosaccharide.
Summary of the invention
For above-mentioned prior art, the invention provides a kind of health food---xylo-oligosaccharide milk sheet of the enhancing immunity containing astragalus polyose, xylo-oligosaccharide, and its preparation method is provided.
The present invention is achieved by the following technical solutions:
An xylo-oligosaccharide milk sheet, is comprised of the component of following weight portion: 5～20 parts of astragalus polyoses, 5～20 parts of xylo-oligosaccharides, 40～80 parts of milk powder, 6～12 parts of xylitols, 0.01～1 part of citric acid, 0.15～0.5 part of dolomol.
Described astragalus polyose be the dry root of legume astragalus mongolicus or Astragalus membranacus through the water-soluble heteroglycan extracting, concentrated, purifying forms, be pale yellow powder, exquisiteness, evenly free from admixture, can buy and obtain from the market.
Described xylo-oligosaccharide is the functional polymerization sugar being combined into β-(Isosorbide-5-Nitrae) glycosidic bond by 2-7 wood sugar molecule.
Described milk powder is whole milk powder, low fat milk powder or skimmed milk power, is conventional products of the prior art, easily buys and obtains from the market.
Xylo-oligosaccharide milk sheet of the present invention, is tablet, during preparation, according to conventional preparation method's preparation.
Xylo-oligosaccharide method for preparing milk tablets of the present invention comprises the following steps:
(1) premix: xylo-oligosaccharide, astragalus polyose, xylitol, citric acid and milk powder are mixed according to weight ratio;
(2) granulation: to the good material of above-mentioned premix spray absolute ethyl alcohol to material hold agglomerating, finger is light press loose till, material is crossed to 20 eye mesh screens, dry (baking temperature is 40～60 ℃);
(3) whole grain: rub the material of opening caking with the hands, make it to be dispersed into uniform particle, dry, pellet moisture is controlled at 5～10%;
(4) compressing tablet: add dolomol in dried particles, send into tablet press machine compressing tablet after mixing, obtain, be then packaged into product by established rules lattice.
Xylo-oligosaccharide milk sheet of the present invention, astragalus polyose and xylo-oligosaccharide is composite, and multiple nutrients agent acting in conjunction can greatly improve nutriment and be worth.The nutriment of long-term supplementary copy invention preparation effectively enhanced machine body immunity function, protect cardiovascular, adjusting body intestinal health etc.
Compared with prior art, the present invention has the following advantages:
1, the astragalus polyose in the present invention is the effective active polysaccharide that the method extracted by Radix Astragali water logging makes, there is the effect that strengthens immunity, make milk sheet with xylo-oligosaccharide, make it have easily take, mouthfeel is good, the feature of easy absorption, has the effect that improves immunity.
2, xylo-oligosaccharide is a kind of efficient prebiotics, and effectively coordinating intestines and stomach is healthy, plays the effect of enhancement to strengthening immunity.Be mixed and made into sugar-free milk sheet with milk powder, xylitol, nutritious, instant; In addition, adding of citric acid not only makes milk sheet mouthfeel better, and can extend the shelf life.
/ the specific embodiment
Below in conjunction with embodiment, the present invention is further illustrated.
Embodiment 1 prepares xylo-oligosaccharide milk sheet
Raw material proportioning following (weight portion, unit be kilogram): astragalus polyose 5, xylo-oligosaccharide 5, milk powder 80, xylitol 8, citric acid 0.02, dolomol 0.3.
Preparation method is: above-mentioned astragalus polyose, xylo-oligosaccharide powder, milk powder, xylosic alcohol powder are mixed, and evenly moistening with ethanol, the mixture after moistening is crossed 20 mesh sieves, dry, and after sieve, whole grain, adds dolomol, compressing tablet, and every heavy 3.5g, obtains.
Embodiment 2 prepares xylo-oligosaccharide milk sheet
Raw material proportioning following (weight portion, unit be kilogram): astragalus polyose 8, xylo-oligosaccharide 12, milk powder 73, xylitol 7, citric acid 0.02, dolomol 0.3.
Preparation method is: above-mentioned astragalus polyose, xylo-oligosaccharide powder, milk powder, xylosic alcohol powder are mixed, and evenly moistening with ethanol, the mixture after moistening is crossed 20 mesh sieves, dry, is sieving, and whole grain, adds dolomol, compressing tablet, and every heavy 3.5g, obtains.
Embodiment 3 prepares xylo-oligosaccharide milk sheet
Raw material proportioning following (weight portion, unit be kilogram): astragalus polyose 12, xylo-oligosaccharide 10, milk powder 70, xylitol 8, citric acid 0.02, dolomol 0.3.
Preparation method is: above-mentioned astragalus polyose, xylo-oligosaccharide powder, milk powder, xylosic alcohol powder are mixed, and evenly moistening with ethanol, the mixture after moistening is crossed 20 mesh sieves, dry, is sieving, and whole grain, adds dolomol, compressing tablet, and every heavy 3.0g, obtains.
Embodiment 4 prepares xylo-oligosaccharide milk sheet
Raw material proportioning following (weight portion, unit be kilogram): astragalus polyose 15, xylo-oligosaccharide 20, milk powder 60, xylitol 5, citric acid 0.02, dolomol 0.3.
Preparation method is: above-mentioned astragalus polyose, xylo-oligosaccharide powder, milk powder, xylosic alcohol powder are mixed, and evenly moistening with ethanol, the mixture after moistening is crossed 20 mesh sieves, dry, is sieving, and whole grain, adds dolomol, compressing tablet, and every heavy 2.0g, obtains.
Embodiment 5 prepares xylo-oligosaccharide milk sheet
Raw material proportioning following (weight portion, unit be kilogram): astragalus polyose 20, xylo-oligosaccharide 10, milk powder 62, xylitol 8, citric acid 0.02, dolomol 0.3.
Preparation method is: above-mentioned astragalus polyose, xylo-oligosaccharide powder, milk powder, xylosic alcohol powder are mixed, and evenly moistening with ethanol, the mixture after moistening is crossed 20 mesh sieves, dry, is sieving, and whole grain, adds dolomol, compressing tablet, and every heavy 2.5g, obtains.
Claims (2)
1. an xylo-oligosaccharide milk sheet, is characterized in that: the component of following weight portion, consist of: 5～20 parts of astragalus polyoses, 5～20 parts of xylo-oligosaccharides, 40～80 parts of milk powder, 6～12 parts of xylitols, 0.01～1 part of citric acid, 0.15～0.5 part of dolomol;
Described astragalus polyose be the dry root of legume astragalus mongolicus or Astragalus membranacus through the water-soluble heteroglycan extracting, concentrated, purifying forms, be pale yellow powder;
Described xylo-oligosaccharide is the functional polymerization sugar being combined into β-(Isosorbide-5-Nitrae) glycosidic bond by 2-7 wood sugar molecule;
Prepare by the following method:
(1) premix: xylo-oligosaccharide, astragalus polyose, xylitol, citric acid and milk powder are mixed according to weight ratio;
(2) granulation: to the good material of above-mentioned premix spray absolute ethyl alcohol to material hold agglomerating, finger is light press loose till, material is crossed to 20 eye mesh screens, dry, baking temperature is 40～60 ℃;
(3) whole grain: rub the material of opening caking with the hands, make it to be dispersed into uniform particle, dry, pellet moisture is controlled at 5～10%;
(4) compressing tablet: add dolomol in dried particles, send into tablet press machine compressing tablet after mixing, obtain.
2. the preparation method of a kind of xylo-oligosaccharide milk sheet claimed in claim 1, is characterized in that: comprise the following steps:
(1) premix: xylo-oligosaccharide, astragalus polyose, xylitol, citric acid and milk powder are mixed according to weight ratio;
(2) granulation: to the good material of above-mentioned premix spray absolute ethyl alcohol to material hold agglomerating, finger is light press loose till, material is crossed to 20 eye mesh screens, dry, baking temperature is 40～60 ℃;
(3) whole grain: rub the material of opening caking with the hands, make it to be dispersed into uniform particle, dry, pellet moisture is controlled at 5～10%;
(4) compressing tablet: add dolomol in dried particles, send into tablet press machine compressing tablet after mixing, obtain.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210537196.9A CN102960456B (en) | 2012-12-12 | 2012-12-12 | Xylooligosaccharide milk tablet |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210537196.9A CN102960456B (en) | 2012-12-12 | 2012-12-12 | Xylooligosaccharide milk tablet |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102960456A CN102960456A (en) | 2013-03-13 |
| CN102960456B true CN102960456B (en) | 2014-10-29 |
Family
ID=47791114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210537196.9A Expired - Fee Related CN102960456B (en) | 2012-12-12 | 2012-12-12 | Xylooligosaccharide milk tablet |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102960456B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104322678A (en) * | 2014-11-15 | 2015-02-04 | 柳州市康小乐牛奶有限公司 | Yogurt containing astragalus polysaccharide |
| CN105941631A (en) * | 2016-06-06 | 2016-09-21 | 陈键 | Yak milk tablets for enhancing immunity and preparation method thereof |
| CN106106757A (en) * | 2016-06-30 | 2016-11-16 | 成都永安制药有限公司 | A kind of preparation method of the milk sheet containing Oligomeric manna sugar |
| CN106359616A (en) * | 2016-08-29 | 2017-02-01 | 杭州天龙集团有限公司 | Flax milk tablets and preparation method thereof |
| CN111387492A (en) * | 2020-04-10 | 2020-07-10 | 内蒙古坤华生物科技有限公司 | Composition for regulating gastrointestinal function and preparation method thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1663573B (en) * | 2004-03-04 | 2010-04-28 | 青岛东海药业有限公司 | A stable and safe microecological formulation, its preparation and usage |
| CN100358428C (en) * | 2005-03-13 | 2008-01-02 | 杨军 | Dry milk piece with astragalus mongholicus for protecting stomach |
| CN101194718A (en) * | 2007-12-08 | 2008-06-11 | 榆林学院 | Method of preparing red date radix astragali polyoses beverage |
| CN101305804A (en) * | 2008-04-11 | 2008-11-19 | 温州医学院 | Antiageing tablet containing Siberian solomonseal rhizome polysaccharide and Radix astragali polysaccharide and its preparation method |
| CN101971884A (en) * | 2010-09-10 | 2011-02-16 | 甘肃岷归中药材科技有限公司 | Micron Chinese angelica and Astragalus membranaceus instant soybean milk powder and preparation method thereof |
-
2012
- 2012-12-12 CN CN201210537196.9A patent/CN102960456B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102960456A (en) | 2013-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102960456B (en) | Xylooligosaccharide milk tablet | |
| CN103431134A (en) | Tablet candy containing prebiotics and preparation method thereof | |
| CN105053782A (en) | Red rice instant powder with health-care functions and preparation method thereof | |
| CN101120747A (en) | Composite material for goose | |
| CN105876637A (en) | Green asparagus noodles and making method thereof | |
| CN103689417A (en) | Health care rice for moistening and beauty treatment and preparation method thereof | |
| CN107048164A (en) | A kind of low sugar rice cake | |
| CN104522679A (en) | A vitamin c chewable tablet | |
| CN107616289A (en) | A kind of mushroom pressed candy and preparation method thereof | |
| CN103109890A (en) | Papaya flour | |
| CN101715827A (en) | Barley almond dairy product and preparation method thereof | |
| CN101642251B (en) | Nutritive rice suitable for middle-aged and elderly people and processing method thereof | |
| CN107751778A (en) | A kind of high microsteping content health caring noodles with effects for removing toxic heat and preparation method thereof | |
| CN107183649A (en) | A kind of preparation of compound fructus amomi seasoning | |
| CN105360558A (en) | Candies capable of expelling toxins, reducing weight and reducing blood fat and production technology of candies | |
| CN105661492A (en) | Full-nutrition food for controlling weight | |
| CN103039847A (en) | Manufacturing method of taro buckwheat fine dried noodles | |
| CN105341704A (en) | Brown sugar red bean paste | |
| CN106473157A (en) | A kind of vegetable protein flour producing process adding Poria and tea polyphenols | |
| CN108936183A (en) | A kind of compound endothelium corneum gigeriae galli solid beverage | |
| CN102048139A (en) | Compound nourishing cellulose | |
| CN102273638A (en) | Fleece-flower root product with addition of mineral nutrient intensifying agent | |
| CN104782722A (en) | Read bean probiotics health biscuit | |
| CN106490480A (en) | A kind of pure plant albumen powder food formula and processing technology for adding bean curd stick and clover | |
| CN105166643A (en) | Dogwood fruit pulp-vanilla pod flour and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20180312 Granted publication date: 20141029 |
|
| PP01 | Preservation of patent right | ||
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20210312 Granted publication date: 20141029 |
|
| PD01 | Discharge of preservation of patent | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20210312 Granted publication date: 20141029 |
|
| PP01 | Preservation of patent right | ||
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20230307 Granted publication date: 20141029 |
|
| PD01 | Discharge of preservation of patent | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141029 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |